Vince Groppi

CEO at Oricula Therapeutics

Dr. Groppi is the Director, the Center for Discovery of New Medicines and Director, the Center for Chemical Genomics at the University of Michigan and a consultant for the NIH/NINDS Blueprint Therapeutic Network (BPN). Dr. Groppi teaches translational pharmacology at the University of Michigan (U-M) and serves on U-M’s Protein Folding Disease Initiative. He received his Ph.D. in Molecular Pharmacology at Rutgers Medical Schools and did his postdoctoral training at the University of California, San Francisco. Dr. Groppi is an expert in pharmacology, neuroscience drug discovery and development, including effectively utilizing cell-based assays to drive SAR. Dr. Groppi was the vice president and chief scientific officer of Essen BioScience, an integrated bioscience company. Previously he held positions at Upjohn, Pharmacia and Pfizer leading discovery, development and strategy teams. See publications.

Links

Previous companies

Pfizer logo
The University of Michigan logo

Timeline

  • CEO

    Current role

  • University of Michigan, Director